Tetrahydrocannabinol (THC) bei Patienten mit Fibromyalgiesyndrom (FMS)Retrospektive Untersuchung zu Veränderungen von Schmerz, psychometrischen Variablen und Analgetikaverbrauch im Verlauf einer interdisziplinären multimodalen stationären Schmerztherapie (IMST)Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS)A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient interdisciplinary multimodal pain therapy (IMPT)

被引：0
作者：
Horst Bettstetter [1 ]
Arne Schäfer [2 ]
机构：
[1] Schmerzzentrum Inn-Salzach,Fachbereich Psychodiabetologie
[2] Diabetes-Klinik Bad Mergentheim,Medizinische Klinik und Poliklinik II
[3] Universitätsklinikum Würzburg,undefined
来源：
Der Schmerz | 2024年 / 38卷 / 4期
关键词：
Medizinisches Cannabis; Schmerzintensität; Depression; Lebensqualität; Analgetikaverbrauch; Medical cannabis; Pain intensity; Depression; Quality of life; Analgesic consumption;
D O I：
10.1007/s00482-023-00727-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：259 / 266
页数：7
相关论文
共 52 条
[1]  
Abuhasira R(2018)Medical use of cannabis and cannabinoids containing products—Regulations in Europe and North America Eur J Intern Med 49 2-6
[2]  
Shbiro L(2020)Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a randomized, double-blind, placebo-controlled clinical trial Pain Med 21 2212-2218
[3]  
Landschaft Y(2020)Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study Clin Exp Rheumatol 38 53-59
[4]  
Chaves C(2018)Medical cannabis for the treatment of fibromyalgia J Clin Rheumatol 24 255-258
[5]  
Bittencourt PCT(1997)International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results J Psychosom Res 42 17-41
[6]  
Pelegrini A(2021)A systematic review of fibromyalgia and recent advancements in treatment: is medicinal cannabis a new hope? Cureus 13 e17332-1386
[7]  
Giorgi V(2016)Do we need a third mechanistic descriptor for chronic pain states? Pain 157 1382-19
[8]  
Bongiovanni S(2020)Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) Harm Reduct J 17 37-17
[9]  
Atzeni F(2018)Practical considerations in medical cannabis administration and dosing Eur J Intern Med 49 12-3086
[10]  
Habib G(2019)Associations of parental marijuana use with offspring marijuana, tobacco, and alcohol use and opioid misuse Jama Netw Open 2 e1916015-1276
123456